SABBY MANAGEMENT, LLC - Q3 2023 holdings

$137 Million is the total value of SABBY MANAGEMENT, LLC's 84 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .

 Value Shares↓ Weighting
ExitHARBOR CUSTOM DEVELOPMENT INC*w$0-753,522
-100.0%
-0.01%
ExitHEARTBEAM INC*w$0-17,908
-100.0%
-0.01%
ExitEFFECTOR THERAPEUTICS INCput$0-107
-100.0%
-0.01%
ExitBONE BIOLOGICS CORP$0-10,817
-100.0%
-0.01%
OG ExitONION GLOBAL LTDads$0-1,200,489
-100.0%
-0.02%
ExitT2 BIOSYSTEMS INC$0-448,900
-100.0%
-0.03%
ExitARCIMOTO INC$0-24,900
-100.0%
-0.03%
CNEY ExitCN ENERGY GROUP INCcl a$0-218,457
-100.0%
-0.04%
ExitGLOBUS MARITIME LTDput$0-529
-100.0%
-0.04%
ExitASCENT SOLAR TECHNOLOGIES INC$0-579,007
-100.0%
-0.06%
ExitBRIGHT GREEN CORPput$0-824
-100.0%
-0.07%
ExitCOSMOS HEALTH INC$0-35,006
-100.0%
-0.09%
ExitSPHERE 3D CORPput$0-843
-100.0%
-0.09%
ExitASSURE HOLDINGS CORP$0-132,610
-100.0%
-0.10%
ExitVERB TECHNOLOGY CO INC$0-129,900
-100.0%
-0.12%
ExitEDIBLE GARDEN AG INC$0-124,100
-100.0%
-0.13%
ExitIBIO INCput$0-2,974
-100.0%
-0.15%
ExitSMART FOR LIFE INC$0-249,385
-100.0%
-0.16%
ExitOCEANPAL INC$0-118,854
-100.0%
-0.16%
ExitKIORA PHARMACEUTICALS INC$0-312,369
-100.0%
-0.16%
ExitNEPTUNE WELLNESS SOLUTIONS INC$0-1,615,607
-100.0%
-0.19%
ExitIMPERIAL PETE INCput$0-795
-100.0%
-0.20%
MOBQ ExitMOBIQUITY TECHNOLOGIES INC$0-2,167,280
-100.0%
-0.20%
ExitADITXT INC$0-589,560
-100.0%
-0.22%
ExitBRIDGEBIO PHARMA INCcall$0-194
-100.0%
-0.27%
RWLK ExitREWALK ROBOTICS LTD$0-567,394
-100.0%
-0.28%
GLBS ExitGLOBUS MARITIME LTD$0-411,907
-100.0%
-0.30%
ExitHILLSTREAM BIOPHARMA INC$0-1,325,219
-100.0%
-0.40%
ExitPANBELA THERAPEUTICS INC$0-235,819
-100.0%
-0.44%
JUPW ExitJUPITER WELLNESS INC$0-1,421,797
-100.0%
-0.49%
ExitAVENUE THERAPEUTICS INC$0-553,338
-100.0%
-0.53%
ExitSHF HOLDINGS INCcl a$0-1,262,779
-100.0%
-0.55%
ExitITERUM THERAPEUTICS PLC$0-75,000
-100.0%
-0.92%
ExitSIDUS SPACE INCcl a$0-6,413,644
-100.0%
-0.95%
ExitSONNET BIOTHERAPEUTICS HLDNG INC$0-3,291,060
-100.0%
-1.32%
ExitBRAINSTORM CELL THERAPEUTICS$0-1,267,871
-100.0%
-2.14%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings